COVID-19 equitable vaccine scheme reaches more than 100 countries and economies

More than 100 countries and economies have now received COVID-19 vaccines through the UN-partnered equitable coronavirus-busting scheme, COVAX.

UN News | Updated: 09-04-2021 00:00 IST | Created: 08-04-2021 23:49 IST
COVID-19 equitable vaccine scheme reaches more than 100 countries and economies
WHO listed two versions of the AstraZeneca-Oxford vaccine, after careful consideration over four weeks of analysis, for emergency use on 15 February, to be rolled out globally through COVAX. Image Credit: ANI

The first delivery of lifesaving jabs arrived in Ghana on 24 February.

Announcing the news on Thursday, the World Health Organization (WHO) said that more than 38 million doses of AstraZeneca, Pfizer-BioNTech and Serum Institute of India produced shots (one of the AstraZeneca vaccines known as COVISHIELD) have been transported globally so far.

AstraZeneca jabs have 'saved millions'

The development comes as WHO and other health regulators reaffirmed the overwhelming value of the AstraZeneca (or AZ) COVID-19 vaccine, amid ongoing concerns about clotting events among a very small number who've had the jab.

WHO listed two versions of the AstraZeneca-Oxford vaccine, after careful consideration over four weeks of analysis, for emergency use on 15 February, to be rolled out globally through COVAX.

In statements on Wednesday evening, the WHO's Global Advisory Committee on Vaccine Safety, the European Medicines Agency and the UK's regulator all concluded that the benefits of taking the AZ vaccine "outweigh the very rare potential risks".

190 million doses

More than 190 million doses of AstraZeneca vaccines have been administered to date, but only 182 cases of clotting have been reported, WHO said, in its advice to countries to continue to vaccinate with the AZ vaccine, noting that it has "saved millions of lives and prevented serious illness".

Despite reduced supply availability in March and April – the result of vaccine manufacturers optimising their production processes in the early phase of the rollout, as well as increased demand for COVID-19 vaccines in IndiaCOVAX "expects to deliver doses to all participating economies that have requested vaccines in the first half of the year", said the press release issued by WHO.

"COVAX has given the world the best way to ensure the fastest, most equitable rollout of safe and effective vaccines to all at-risk people in every country on the planet," said WHO chief, Tedros Adhanom Ghebreyesus.

"If we are going to realize this great opportunity, countries, producers and the international system must come together to prioritize vaccine supply through COVAX. Our collective future, literally, depends on it."

'Time to accelerate'

Henrietta Fore, UNICEF Executive Director, said that despite all that had been achieved in just a month and a half, "this is no time to celebrate; it is time to accelerate.

"With variants emerging all over the world, we need to speed up global rollout. To do this, we need governments, along with other partners, to take necessary steps to increase supply, including by simplifying barriers to intellectual property rights, eliminating direct and indirect measures that restrict exports of COVID-19 vaccines, and donating excess vaccine doses as quickly as possible."

© UNICEF/Seyba KeïtaMali rolls out its vaccination programme against COVID-19 in Bamako with 396,000 doses of vaccines provided under the COVAX Facility.

"It is tremendously gratifying that the roll-out of COVAX doses has already reached one hundred countries," said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.

'Daunting challenge'

"COVAX may be on track to deliver to all participating economies in the first half of the year yet we still face a daunting challenge as we seek to end the acute stage of the pandemic: we will only be safe when everybody is safe and our efforts to rapidly accelerate the volume of doses depend on the continued support of governments and vaccine manufacturers."

According to its latest supply forecast, COVAX expects to deliver at least 2 billion doses of vaccines in 2021, which will mean having to continue adding new vaccines to its portfolio. New agreements with manufacturers are being announced "in due course", according to WHO and partners.

Last month, it was announced that the United States would host a launch event – taking place next week - for what's being called the Gavi COVAX AMC Investment Opportunity, referring to the COVAX Advance Market Commitment, which aims to ensure that the world's poorest nations get access to the life-saving vaccines.

An additional $2 billion is required in 2021 to finance and secure up to a total of 1.8 billion donor-funded doses of vaccines. The COVAX partnership is also working to secure additional sourcing of vaccines in the form of dose-sharing from higher-income countries.

Visit UN News for more.


TRENDING

OPINION / BLOG / INTERVIEW

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Privacy and data protection: Reviewing notable policy frameworks

The evolved privacy principles and the resulting legislation across the world primarily aim to force the data collector to define the purpose for which the data is being collected along with the need to obtain explicit consent for the said ...

Videos

Latest News

Inox Leisure commences operations at new multiplex in Bangalore

Multiplex operator Inox Leisure on Tuesday said it has commenced commercial operations at a new multiplex in Bangalore in Karnataka, taking its total count to 153. The company has commenced the commercial operations of a multiplex cinema th...

What you need to know about the coronavirus right now

Heres what you need to know about the coronavirus right now Indias 161,736 new coronavirus infections are worlds highestIndia reported 161,736 new coronavirus infections on Tuesday, hitting the worlds highest daily tally once again, for a t...

Sputnik V vaccine authorized in India

India has become the 60th country to approve Sputnik V Sputnik V is one of only three vaccines registered in India The Russian vaccine has been approved for use in countries with total population of 3 billion people MOSCOW, April 12, 2021 P...

INOXCVA signs MoU with Mitsui - Partnership will enhance small scale LNG applications development and provide impetus to gas based economy in the country

MUMBAI, India, April 12, 2021 PRNewswire -- Indian multinational and one of the worlds leading Cryogenic Liquid Storage, Distribution and Re-Gas solutions provider, INOXCVA today announced that it has signed a Memorandum of Understanding wi...

Give Feedback